EGRIFTA MDV Trademark

Trademark Overview

On Friday, February 25, 2022, a trademark application was filed for EGRIFTA MDV with the United States Patent and Trademark Office. The USPTO has given the EGRIFTA MDV trademark a serial number of 97285560. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Sunday, May 18, 2025. This trademark is owned by Theratechnologies Inc.. The EGRIFTA MDV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease
egrifta mdv

General Information

Serial Number97285560
Word MarkEGRIFTA MDV
Filing DateFriday, February 25, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSunday, May 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTheratechnologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMontreal, Quebec H3A1T8
CA

Trademark Events

Event DateEvent Description
Thursday, March 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2022NEW APPLICATION ENTERED
Thursday, December 8, 2022ASSIGNED TO EXAMINER
Monday, December 12, 2022SUSPENSION LETTER WRITTEN
Monday, December 12, 2022LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 28, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, July 3, 2023SUSPENSION INQUIRY WRITTEN
Monday, July 3, 2023INQUIRY TO SUSPENSION E-MAILED
Monday, July 3, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, September 21, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, February 12, 2024ASSIGNED TO LIE
Monday, February 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2024SUSPENSION LETTER WRITTEN
Monday, February 12, 2024LETTER OF SUSPENSION E-MAILED
Monday, February 12, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, January 19, 2025INQUIRY TO SUSPENSION E-MAILED
Sunday, May 18, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, May 18, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 14, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, January 19, 2025SUSPENSION INQUIRY WRITTEN
Sunday, January 19, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Related Keywords

egrifta nonalcoholic injury traumatic brain steathohepatitis disease liver fatty impairment cognitive